INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.890
+0.060 (3.28%)
At close: Oct 9, 2026, 4:00 PM EDT
1.895
+0.005 (0.26%)
After-hours: Oct 9, 2026, 7:30 PM EDT
INmune Bio Employees
INmune Bio had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year. That makes INmune Bio the 38,178th largest employer in the world and 5,474th in the United States.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$876,952
Market Cap
52.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2024 | 22 | 5 | 29.41% | 13 | 9 |
| Dec 31, 2023 | 17 | 7 | 70.00% | 11 | 6 |
| Dec 31, 2022 | 10 | 0 | - | 10 | 0 |
| Dec 31, 2021 | 10 | 5 | 100.00% | 10 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Clene | 79 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
INMB News
- 3 days ago - INmune Bio to Attend the 2026 Maxim Growth Summit - GlobeNewsWire
- 25 days ago - INmune Bio Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 25 days ago - INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board - GlobeNewsWire
- 4 weeks ago - INmune Bio to Present at the H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 6 weeks ago - INmune Bio submits two regulatory packages to EMA for Ebstrocel - TheFly
- 6 weeks ago - INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings - GlobeNewsWire
- 2 months ago - INmune Bio Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - INmune Bio Quarterly report: Q2 2026 - Filings